Related Experiment Videos
Myosin mutations in hypertrophic cardiomyopathy and functional implications
1Max-Planck-Institut für physiologische und klinische Forschung, Abteilung Experimentielle Kardiologie, Bad Nauheim.
Insights
Hypertrophic cardiomyopathy (HCM) is often inherited, with genetic mutations identified in the beta myosin heavy chain gene. Research suggests mutations, particularly at amino acid position 403, may disrupt the cardiac contractile cycle.
Area of Science:
- Genetics
- Molecular Biology
- Cardiology
Background:
- Hypertrophic cardiomyopathy (HCM) is a significant inherited cardiac disorder, with genetic factors implicated in approximately 50% of cases.
- HCM exhibits dominant inheritance patterns, with four distinct genetic loci identified on chromosomes 1, 11, 14, and 15.
- The beta myosin heavy chain gene on chromosome 14 is the sole identified causative gene to date.
Purpose of the Study:
- To review the current understanding of genetic mutations in hypertrophic cardiomyopathy (HCM).
- To explore the role of the beta myosin heavy chain gene and specific mutations in HCM pathogenesis.
- To highlight the need for further molecular and genetic research to elucidate disease mechanisms.
Main Methods:
- Review of existing literature on hypertrophic cardiomyopathy (HCM) genetics.
- Analysis of identified mutations within the beta myosin heavy chain gene.
- Inference of functional consequences based on published data and protein structure.
Main Results:
- The beta myosin heavy chain gene, expressed in cardiac ventricles, harbors numerous missense mutations, predominantly in the globular head region.
- A mutation 'hot spot' is identified within exon 13, specifically at amino acid position 403.
- While functional consequences remain largely unknown, mutations at position 403 are hypothesized to affect myosin-actin dissociation during muscle contraction.
Conclusions:
- Genetic mutations in the beta myosin heavy chain gene are strongly associated with hypertrophic cardiomyopathy (HCM).
- Specific mutations, such as those at amino acid 403, may directly impact cardiac muscle function.
- Further molecular and genetic investigations are crucial to fully understand the pathogenesis of myosin-related heart disease.
Abstract:
Hypertrophic cardiomyopathy (HCM) can be an inherited disorder. Typically, the inheritance is dominant and genetic cases account for about 50% of all patients with this pathology. Four different HCM loci have been mapped to different chromosomes (no. 1, 11, 14 and 15), yet, only one responsible gene has been identified. It is the beta myosin heavy chain gene on chromosome 14, which is expressed in ventricles and in slow skeletal muscle fibers. A large number of missense mutations has been reported which are predominantly located in the globular head region of the beta myosin. An apparent hot spot of mutation has been detected within exon 13 of the gene, corresponding to amino acid position 403. Although the functional consequences of the various mutations for the activity of beta myosin are not known, by inference and on the basis of published data, it may be suggested that a mutation in position 403 affects the myosin-actin dissociation in the contractile cycle. Despite our knowledge of mutations in the myosin gene, and of many of the pathological sequelas, there still is insufficient information which precludes unequivocal conclusions on the molecular mechanisms by which the pathogenesis of the myosin deficient heart develops. Molecular biology and genetics should help to define the determinants of this disease.